Other Clinical Trial - Study to Obtain Blood & Voided Urine Samples to

Status Completed

Clinical Trial Summary

Clinical samples [blood and voided urine (only for phase A)] from patient recruited at Sihanouk Hospital Centre of HOPE (SHCH) and HOPE Community Medical Center (CMC) will be processed (decontamination) and shipped to SRI International with the purpose of design and validation (proof of concept) and (case/control series) of in-vitro diagnostics for melioidosis.

Clinical Trial Description

Study will be proposed to all patients at Sihanouk Hospital Centre of HOPE (SHCH) and HOPE Community Medical Center (CMC) presenting with systemic inflammatory response syndrome (SIRS).

Blood samples will be collected upon admission for patients with blood culture request as part of routine patient care and agreement on informed consent. A second sample will be collected in patients with blood culture proven melioidosis or suspicion of melioidosis (only for phase B), at day 5 after initiation of appropriate antibiotic treatment. Depending on the final diagnosis, a subset of patients will be assigned to 3 groups:

1. Patients for whom blood cultures grew Burkholderia pseudomallei

2. Patients for whom blood cultures did not grow a pathogen, but have other body site grown with Burkholderia pseudomallei, or are suspected of melioidosis

3. Patients for whom blood cultures grew with another pathogen

In phase A only, at least 20 ml of voided urine will be collected when a patient is hospitalized and identified as belonging to study group 1, 2 or 3. A second collection of voided urine will be collected for group 1 and 2 patients during routine further hospital stay or a routine follow-up visit.

The clinical samples from these patients will be processed and shipped to SRI International with the purpose of design (=phase A) and validation (=phase B) of in-vitro diagnostics for melioidosis.

A coded database will be completed with basic demographic, clinical and microbiological data and final diagnosis. This coded information will be provided to SRI International. ;

Study Design

Related Conditions & MeSH terms

Melioidosis
Suspected or Confirmed Bloodstream Infections
Systemic Inflammatory Response Syndrome

Clinical Trial Details

NCT number	NCT02668406
Study type	Observational
Source	Institute of Tropical Medicine, Belgium
Contact
Status	Completed
Phase
Start date	February 2016
Completion date	September 30, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02902939` - Myeloid-Derived Supressor Cells in Cardiac Surgery Patients	N/A
Completed	`NCT02518087` - Increased Adsorption Membranes During Cardiopulmonary Bypass	N/A
Completed	`NCT02563652` - Can Biomarkers Aid in the Prediction of Postoperative Pain and Circulatory Instability After Major Abdominal Surgery?
Recruiting	`NCT01157299` - Hemodynamic Evaluation of Preload Responsiveness in Children by Using PiCCO	N/A
Completed	`NCT01388725` - Comparison the Value of Several Biomarkers of Sepsis	N/A
Unknown status	`NCT00254176` - Cysteine Supplementation in Critically Ill Neonates	Phase 2/Phase 3
Not yet recruiting	`NCT03617796` - Prognostic Value of CD64 Marker for Patients in Intensive Care Unit
Completed	`NCT03876041` - Evaluation of Corticosteroid in Systemic Inflammatory Response Syndrome	Phase 4
Recruiting	`NCT05608096` - European Registry for Hemadsorption in Sepsis With the Seraph Filter
Completed	`NCT03314831` - The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
Completed	`NCT02568410` - Platelets as Regulators of Inflammation in Cardiac Surgery
Completed	`NCT01636232` - Vitamin D and Critically Ill Patients	N/A
Completed	`NCT01020409` - INFLACOR - Clinical and Genetic Predictors of Inflammation Related Complications After Heart Surgery	Phase 4
Completed	`NCT04624776` - Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest	Phase 2
Recruiting	`NCT05172739` - Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC	Phase 4
Recruiting	`NCT02957175` - Immunophenotyping of Patients With Postoperative SIRS
Completed	`NCT02320539` - MicroRNA Diagnostics in Subarachnoid Hemorrhage 2	N/A
Completed	`NCT01708759` - IL8 Monitoring and Its Correlation With 251-gene Polymorphism	N/A
Terminated	`NCT00708799` - Efficacy of Macrolide Immunomodulation in Severe Sepsis.	Phase 2
Recruiting	`NCT04580680` - Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Study to Obtain Blood and Voided Urine Samples to Improve the Diagnosis of Melioidosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms